In order to assess the continuing need for use of dental amalgam in relation to specific medical needs, importers and manufacturers should inform the competent authorities every year of the quantities imported or manufactured for such medical needs. Moreover, by 31 December 2029, the Commission should assess if it is still necessary to maintain the derogation for the import and manufacturing of dental amalgam used for patients with specific medical needs, taking into account the availability of mercury-free alternatives for the relevant patient groups.
Recital 8, Regulation (EU) 2024/1849
In forcesince 13 Jun 2024